The following pages link to Victor de Gruttola (Q1305605):
Displaying 46 items.
- Analysis of Doubly-Censored Survival Data, with Application to AIDS (Q153262) (← links)
- (Q830651) (redirect page) (← links)
- (Q1020668) (redirect page) (← links)
- Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times (Q830652) (← links)
- Sampling dynamic networks with application to investigation of HIV epidemic drivers (Q900178) (← links)
- Efficient hybrid EM for linear and nonlinear mixed effects models with censored response (Q1020669) (← links)
- Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial (Q1305606) (← links)
- (Q2001886) (redirect page) (← links)
- Estimation of the overall treatment effect in the presence of interference in cluster-randomized trials of infectious disease prevention (Q2001887) (← links)
- Flexible covariate-adjusted exact tests of randomized treatment effects with application to a trial of HIV education (Q2441852) (← links)
- Accommodating Uncertainty in a Tree Set for Function Estimation (Q2863954) (← links)
- Characterizing the Relationship Between HIV-1 Genotype and Phenotype: Prediction-Based Classification (Q3078915) (← links)
- Nonparametric Mixed-Effects Models for Repeated Binary Data Arising in Serial Dilution Assays: An Application to Estimating Viral Burden in AIDS (Q3128645) (← links)
- Recursive partitioning of resistant mutations for longitudinal markers based on a U-type score (Q3165547) (← links)
- Combining Genotype Groups and Recursive Partitioning: An Application to Human Immunodeficiency Virus Type 1 Genetics Data (Q3435811) (← links)
- Resampling-Based Multiple Testing Methods with Covariate Adjustment: Application to Investigation of Antiretroviral Drug Susceptibility (Q3506474) (← links)
- Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses (Q3592124) (← links)
- Influence Analysis of Generalized Least Squares Estimators (Q3783379) (← links)
- Nonparametric analysis of truncated survival data, with application to AIDS (Q3796544) (← links)
- A Nonparametric Test of Gene Region Heterogeneity Associated With Phenotype (Q4468393) (← links)
- A Model for Markers and Latent Health Status (Q4512938) (← links)
- A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials (Q4548231) (← links)
- Impact of Time to Start Treatment Following Infection with Application to Initiating HAART in HIV‐Positive Patients (Q4649049) (← links)
- Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS (Q4836966) (← links)
- Modelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time (Q4844274) (← links)
- Regression Analysis of Censored and Truncated Data: Estimating Reporting- Delay Distributions and AIDS Incidence from Surveillance Data (Q4844300) (← links)
- Analyzing Doubly Censored Data with Covariates, with Application to AIDS (Q5286897) (← links)
- Accounting for interactions and complex inter‐subject dependency in estimating treatment effect in cluster‐randomized trials with missing outcomes (Q5355226) (← links)
- Joint Modeling of Progression of HIV Resistance Mutations Measured with Uncertainty and Failure Time Data (Q5427399) (← links)
- Nonparametric Tests for Two‐Group Comparisons of Dependent Observations Obtained at Varying Time Points (Q5427417) (← links)
- Combining Cross‐Sectional and Prospective Data Methods to Improve Transition Parameter Estimation for Characterizing the Accumulation of HIV‐1 Drug Resistance Mutations (Q5434901) (← links)
- A Resampling-Based Approach to Multiple Testing with Uncertainty in Phase (Q5442946) (← links)
- Validation and Discovery in Markov Models of Genetics Data (Q5700489) (← links)
- A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival (Q5715353) (← links)
- Estimating contact network properties by integrating multiple data sources associated with infectious diseases (Q6626884) (← links)
- A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption (Q6627406) (← links)
- Novel methods for the analysis of stepped wedge cluster randomized trials (Q6627497) (← links)
- Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design (Q6627615) (← links)
- Discussion of article by Ellenberg and Morris (Q6627798) (← links)
- Investigation of patient-sharing networks using a Bayesian network model selection approach for congruence class models (Q6628097) (← links)
- Locally efficient estimation of marginal treatment effects when outcomes are correlated: is the prize worth the chase? (Q6632693) (← links)
- Predicting time to threshold for initiating antiretroviral treatment to evaluate cost of treatment as prevention of human immunodeficiency virus (Q6639069) (← links)
- Two-sample tests of area-under-the-curve in the presence of missing data (Q6644505) (← links)
- Testing for associations with missing high-dimensional categorical covariates (Q6644528) (← links)
- Targeted maximum likelihood estimation of effect modification parameters in survival analysis (Q6644682) (← links)
- Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices (Q6644736) (← links)
- A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis (Q6644751) (← links)
